Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BARRATT DEVELOPMENTS PLC. We currently have 10 research reports from 2 professional analysts.
|17Mar17 15:07||RNS||Director/PDMR Shareholding|
|01Mar17 10:15||RNS||Total Voting Rights|
|22Feb17 12:34||RNS||Holding(s) in Company|
|22Feb17 07:00||RNS||Half-year Report|
|08Feb17 16:11||RNS||Holding(s) in Company|
|01Feb17 10:05||RNS||Total Voting Rights|
|23Jan17 09:40||RNS||Block listing Interim Review|
Frequency of research reports
Research reports on
BARRATT DEVELOPMENTS PLC
BARRATT DEVELOPMENTS PLC
23 Feb 17
The Dow Jones notched up its 9th consecutive all-time high last night, buoyed by Du Pont shares spiking on the news that it is likely to win conditional approval for its proposed US$130bn merger with Dow Chemicals. By comparison the S&P 500 and NASDAQ closed with fractional losses, as Fed Minutes appeared to keep the expectation of a hike at the next two-day FOMC meeting stating on 15th March alive, while slipping commodity prices also saw mining stocks under pressure. Asia was weaker across the board, although a range-bound the Nikkei recovered most of its early losses after the Yen weakened against the US$ following the BOJ's Kiuchi voicing concern over Trump's reflationary and growth programmes; the region's other principal bourses fell more convincingly albeit on relatively light volumes. London continued to be dominated by individual corporate stories, with stronger than expected earnings reports emerging from Lloyds Banking Group (LLOY.L), Barratt Developments (BDEV.L)and UBM (UBM.L) keeping the main indices pointing upward, while Unilever (ULVR.L) also spiked higher as its management responded to a view that it is 'not a case of if, but when' Heinz will return with a second merger proposal by increasing its guidance for margin growth and promising to capture value for shareholders more quickly. Traders also warmed to the second estimate of UK GDP from the ONS showing that growth advanced 0.7% sequentially in the fourth quarter, slightly faster than the 0.6% growth estimated on January 26th and higher than level achieved in the third quarter. Indeed, firm consumer sentiment, continuing low interest rates and a weak pound are now suggesting consensus expectations of just 1.4% for 2017 could now be slightly too low, although a beady eye is still being kept on the inflationary effects of higher input costs. Other than the CBI Distributive Trades Survey for February and CML Mortgage lending numbers, there is little significant macro news due from the UK today, although a large batch of US data, ranging from Initial Jobless, Housing Prices and the Chicago Fed National activity Index, will be accompanied by a speech from the Fed's Dennis Lockhart. A large number of UK corporates are due to release earnings or trading updates this morning, including Barclays (BARC.L), BAT (BATS.L), Centrica (CNA.L), Glencore (GLEN.L), Howdens (HWDN.L) and RSA Insurance (RSA.L). With most portfolio managers already having positioned themselves ahead of the President's next major announcement, which is expected to come with next Tuesday's State of the Union Address, London is seen opening quietly unless that emerges any significant surprises from scheduled corporate releases, leaving the FTSE-100 between flat and 5 points firmer in early trade.
17 Nov 16
"The Fed's Patrick Harker yesterday spelt out just how complex policy on interest rates has now become. Janet Yellen's own testimony this afternoon, which is seen as key to December's FOMC decision, will have to grapple with all the new uncertainties injected by the President-elect, ranging from regressive tax cuts, booming infrastructure spending, financial deregulation and cuts in federal spending. No easy task, even if the markets appear more convinced than ever that the first hike since 2006 will be delivered next month and that this will be the first of a series of such moves over the subsequent 18 or so months as inflation climbs. The recent phase of asset repricing, nevertheless, took a breather yesterday, with all principal markets making only fractional movements. The Dow Jones broke its record run to drift into the red as financials retrenched, while momentum in technology stocks meant the NASDAQ still managed to close modestly up. Asia also put in just marginal movements across the board, as oil prices went lower on weekly data detailing a large rise in inventories, while the Bank of Japan surprised traders with its plans to buy unlimited JGBs at fixed rates in its latest daily market operation. The latter, of course, being seen as it effort to ensure domestic rates do not find themselves shackled to the US T-bill's upward movements. Today, the UK is due to release retail sales figures while the CML provides mortgage lending data; Eurozone inflation numbers are also expected this morning. Clearly the principal event of the day, however, will be Janet Yellen's Testimony on Capitol Hill which is due to commence at 10:00hrs EST and likely overshadow speeches also due from the Fed's William Dudley and Lael Brainard; the US is due to release inflation, weekly jobless claims and export statistics this afternoon as well. Another busy day for UK corporates, with earnings or trading updates scheduled from the likes of CRH (CRH.L), Great Portland Estates (GPOR.L), Johnson Matthey (JMAT.L), Kier Group (KIER.L), Premier Oil (PMO.L), Royal Mail (RMG.L), Shanks (SKS.L), Ted Baker (TED.L), TT Electronics (TTG.L) and Watkin Jones (WJG.L). The FTSE-100 is expected to open virtually unchanged." - Barry Gibb, Research Analyst
24 Mar 17
We note the share transaction yesterday, and think the stock will benefit from the increased liquidity. We continue to believe there is good valuation upside to the shares. However, we are terminating coverage of Watkins Jones from this morning and withdrawing our forecasts from the market.
Outperformance in the bag
24 Mar 17
IG Design has had a very good second half trading and has issued a year-end update indicating that numbers will exceed market estimates. We have lifted our FY17 and FY18 numbers by 8-10% at the pre-tax and EPS levels, following an 11% uplift to earnings with the interims. Particularly notable is the comment on strong cash flow, with the group reaching its target of average leverage less than 2.5x EBITDA two years ahead of plan. With the earnings and cash flow momentum, strong balance sheet and progressive dividend, there is good potential for further share price upside.
N+1 Singer - Morning Song 28-03-2017
28 Mar 17
A G Barr (BAG LN) Share buybacks the main news around FY17 finals | Churchill China (CHH LN) An excellent set of 2016 results and more upgrades | Ergomed (ERGO LN) FY results show strong Services growth; Phase III Zoptrex® data ahead | Instem (INS LN) Investment to accelerate growth trajectory | Severfield (SFR LN) Strong H2 drives upgrades; CEO temporarily steps down due to ill health | Summit Therapeutics (SUMM LN) Strengthening the data package: planned extension of PhaseOut DMD | T. Clarke (CTO LN) Strong conclusion to FY16, record order book
Share & share alike
29 Mar 17
In a key week in a number of respects, some of the optimism that buoyed up markets has dissipated. In the UK, inflation istrending higher and above wage growth, putting pressure on the consumer although retail sales show contrasting signs. Corporate action continues apace. Yesterday there were more than fifty company results – all appear to be at least as expected. We now face a prolonged period of pre-Brexit bargaining. In Share News & Views we have covered Cropper (James)*, ECSC*, Gamma Communications, Goodwin*, Helios*, Manx Telecom, Personal Group and Quarto Group.-